BriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meeting Pharmaceutical Investing
Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments Pharmaceutical Investing
Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics , Seagen Inc. , Provention Bio Inc. , Kimball International, Inc. Pharmaceutical Investing
AbbVie Showcases Strength of Dermatology Portfolio with New Data Presented at the 2023 AAD Annual Meeting Pharmaceutical Investing
BetterLife Files Amended and Restated Offering Document for Offering of Units Pharmaceutical Investing
KEYTRUDA® Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Advanced Malignant Pleural Mesothelioma Pharmaceutical Investing
